Schelman William

Schelman William is listed in filings as Chief Medical Officer at Bicara Therapeutics Inc. Common Stock. This profile follows SEC Form 4 activity through May 12, 2026, including 1 public disclosure. Recent filings connect the profile to Bicara Therapeutics Inc. Common Stock (BCAX). The current snapshot covers public activity from May 12, 2026. Reported amounts are shown as $1.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.